Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Durata Therapeutics Company Profile (NASDAQ:DRTX)

Consensus Ratings for Durata Therapeutics (NASDAQ:DRTX) (?)
Ratings Breakdown: 5 Hold Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $20.50 (15.15% downside)

Current Analysts' Coverage Summary for Durata Therapeutics (NASDAQ:DRTX)
Show:
DateFirmActionRatingPrice TargetActions
10/15/2014Roth CapitalDowngradeBuy -> Neutral$23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/14/2014Credit SuisseDowngradeOutperform -> Neutral$25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/7/2014RBC CapitalDowngradeOutperform -> Sector PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/6/2014JMP SecuritiesDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/8/2014Jefferies GroupLower Price Target$15.00 -> $12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/20/2014GabelliInitiated CoverageHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/23/2014MLV & Co.Initiated CoverageBuy$21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/9/2014Summer StreetInitiated CoverageBuy$22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/6/2014Craig HallumInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/2/2013WedbushDowngradeOutperform -> Neutral$13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/13/2013Janney Montgomery ScottInitiated CoverageBuy$19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/29/2013 forward)